Relay Therapeutics (RLAY) Depreciation and Depletion (2019 - 2026)

Relay Therapeutics (RLAY) has 8 years of Depreciation and Depletion data on file, last reported at $504000.0 in Q1 2026.

• On a quarterly basis, Depreciation and Depletion fell 58.28% year-over-year to $504000.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 45.94% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 34.9% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $504000.0, down from $599000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for RLAY reached as high as $1.4 million in Q1 2024 and fell as low as $504000.0 in Q1 2026.
• Historically, Depreciation and Depletion has averaged $1.1 million across 5 years, with a median of $1.2 million in 2023.
• Across the five-year window, Depreciation and Depletion jumped 39.54% in 2023 and sank 58.28% in 2026, its largest moves.
• Year by year, Depreciation and Depletion stood at $1.2 million in 2022, then climbed by 17.92% to $1.4 million in 2023, then dropped by 2.98% to $1.3 million in 2024, then plunged by 55.1% to $599000.0 in 2025, then retreated by 15.86% to $504000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $504000.0 in Q1 2026, $599000.0 in Q4 2025, and $748000.0 in Q3 2025.